Pharmaceutical industry – Page 50
-
Business
Bayer buys Conceptus for $1.1bn
Deal gives German pharma giant access to surgery-free permanent birth control procedure
-
Business
US sues Novartis over alleged kickbacks
Company fraudulently paid pharmacies to switch patients onto its drugs, government claims
-
BusinessIreland picks preferred drugs
Using the cheapest of equivalent options could save healthcare providers millions
-
Business
Objections raised to GSK pay-for-delay deals
The UK Office of Fair Trading believes deals to delay generic drugs infringed competition laws
-
BusinessThermo Fisher to buy Life Technologies in $15.8bn deal
Equipment suppliers unite, bringing Thermo into life sciences and sequencing markets
-
FeatureFrom molecules to medicines
Turning an active drug molecule into a finished product requires as much chemistry as developing the drug in the first place, as Phillip Broadwith discovers
-
Business
Morning sickness drug reintroduced to US
After being withdrawn due to litigation, the drug has been approved by the FDA
-
BusinessIndia rejects Novartis patent appeal
Supreme court uphold decision to refuse protection for Glivec
-
Business
Roche to release Tamiflu trial data
The company will drip feed data to the Cochrane Collaboration, but with some elements redacted
-
Business
Amylin headquarters to close with further job losses
Bristol-Myers Squibb plans to shutter the San Diego, US, site following last year’s merger
-
Opinion
From lab to leader
Derek Lowe asks (with some trepidation): do drug companies need scientists at the top?
-
Business
Russian investment vehicle sets sights on innovative drugs
Rusnano hopes to make a killing by investing in new technologies in the pharmaceutical sector
-
Business
Court convicts ex-Aptuit researcher over drug data
Altered liquid chromatography results at Scottish site lead to first successful good lab practice prosecution
-
Business
AstraZeneca partners with Moderna for $240 million
Pharma company sheds more jobs and backs messenger RNA therapeutics
-
BusinessGlobal AstraZeneca restructuring will cost 1600 jobs
Firm will focus drug development efforts in three strategic R&D centres in the UK, Sweden and the US
-
Business
Interpol teams up with pharma
Pharmaceutical crime programme will seek to reduce trade in fake drugs
-
Opinion
New antibiotics: what's the hold up?
It’s more a research problem, than a commercial one, says Derek Lowe
-
Business
Alcohol dependence pill approved in EU
Selincro tablets from Lundbeck designed to reduce consumption of alcohol
-
BusinessUK considers patent rule change for trials
Government to change law that organisations say makes the country less appealing as a location for clinical trials
-
Business
Talk of a $6.6bn deal for Elan
Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights